Search
Descriptor English: Cytochrome P-450 CYP2C9
Descriptor Spanish: Citocromo P-450 CYP2C9
Descriptor citocromo P-450 CYP2C9
Scope note: Subtipo de citocromo P-450 con especificidad para los XENOBIÓTICOS acídicos. Oxida un amplio rango de medicamentos de la categoría de los AGENTES ANTIINFLAMATORIOS NO ESTEROIDEOS, HIPOGLUCEMIANTES, ANTICOAGULANTES y DIURÉTICOS.
Descriptor Portuguese: Citocromo P-450 CYP2C9
Descriptor French: Cytochrome P-450 CYP2C9
Entry term(s): CYP2C9
CYP2C9, Cytochrome P-450
CYPIIC9
Cytochrome P 450 CYP2C9
Cytochrome P450 MP 4
Cytochrome P450 MP 8
Cytochrome P450 MP-4
Cytochrome P450 MP-8
Cytochrome P450 PB 1
Cytochrome P450 PB-1
MP-4, Cytochrome P450
MP-8, Cytochrome P450
P-450 CYP2C9, Cytochrome
P450 MP-4, Cytochrome
P450 MP-8, Cytochrome
P450 PB-1, Cytochrome
PB-1, Cytochrome P450
Tree number(s): D08.244.453.491.500.500
D08.811.682.690.708.170.450.500.500
D12.776.422.220.453.491.500.500
RDF Unique Identifier: https://id.nlm.nih.gov/mesh/D065729
Scope note: A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.
Allowable Qualifiers: AD administration & dosage
AE adverse effects
AN analysis
BI biosynthesis
BL blood
CF cerebrospinal fluid
CH chemistry
CL classification
CS chemical synthesis
DE drug effects
DF deficiency
EC economics
GE genetics
HI history
IM immunology
IP isolation & purification
ME metabolism
PD pharmacology
PH physiology
PK pharmacokinetics
PO poisoning
RE radiation effects
SD supply & distribution
ST standards
TO toxicity
TU therapeutic use
UL ultrastructure
UR urine
Entry Combination: antagonists & inhibitors:Cytochrome P-450 CYP2C9 Inhibitors
Registry Number: EC 1.14.13.-
Previous Indexing: *Aryl Hydrocarbon Hydroxylases (2003-2014)
Public MeSH Note: 2015
History Note: 2015
DeCS ID: 55610
Unique ID: D065729
Documents indexed in the Virtual Health Library (VHL): Click here to access the VHL documents
Date Established: 2015/01/01
Date of Entry: 2014/06/26
Revision Date: 2016/05/27
Cytochrome P-450 CYP2C9 - Preferred
Concept UI M0590597
Scope note A cytochrome P-450 subtype that has specificity for acidic XENOBIOTICS. It oxidizes a broad range of important clinical drugs that fall under the categories of NONSTEROIDAL ANTI-INFLAMMATORY AGENTS; HYPOGLYCEMIC AGENTS; ANTCOAGULANTS; and DIURETICS.
Preferred term Cytochrome P-450 CYP2C9
Entry term(s) CYP2C9
CYP2C9, Cytochrome P-450
CYPIIC9
Cytochrome P 450 CYP2C9
Cytochrome P450 MP 4
Cytochrome P450 MP 8
Cytochrome P450 MP-4
Cytochrome P450 MP-8
Cytochrome P450 PB 1
Cytochrome P450 PB-1
MP-4, Cytochrome P450
MP-8, Cytochrome P450
P-450 CYP2C9, Cytochrome
P450 MP-4, Cytochrome
P450 MP-8, Cytochrome
P450 PB-1, Cytochrome
PB-1, Cytochrome P450



We want your feedback on the new DeCS / MeSH website

We invite you to complete a survey that will take no more than 3 minutes.

Go to survey